A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients (Q2861803): Difference between revisions
From MaRDI portal
Latest revision as of 01:33, 7 July 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients |
scientific article |
Statements
A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients (English)
0 references
11 November 2013
0 references
Bayesian statistics
0 references
clinical trial
0 references
dose-escalation study
0 references
dynamic treatment regime
0 references
nonmixture cure model
0 references
0 references